arrow
H

Hideaki Tani

keio university
H指数:16
被引数:826

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The association between amygdalar volume changes and depressive symptom improvements after repeated ketamine infusion in treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with the following open-label study

杏仁核体积变化与重复性氯胺酮输注后难治性抑郁症患者抑郁症状改善之间的关联:一项双盲、随机、安慰剂对照试验及一项开放标签研究

2025-08-140
PRE
Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution

基于AMPA受体分布的双相障碍与重度抑郁障碍的鉴别

2025-08-070
OA
Glutamate plus glutamine to GABA ratio as a predictor of ketamine response in treatment-resistant depression: A double-blind, randomized , open-label extension study

谷氨酸加谷氨酰胺与GABA比率作为预测氯胺酮疗效的指标:一项双盲、随机、开放标签扩展研究

2025-06-050
PRE
MAGNETIC SUBCORTICAL SUSCEPTIBILITY IS ASSOCIATED WITH THE TREATMENT OUTCOME OF REPEATED KETAMINE INFUSION FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

磁化率加权成像测量的皮层下磁化率与抗抑郁药治疗无效患者重复性氯胺酮输注的治疗效果相关

2025-02-120
OA
EFFICACY AND SAFETY OF INTRAVENOUS KETAMINE TREATMENT IN JAPANESE PATIENTS WITH TREATMENT-RESISTANT DEPRESSION: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL

日本难治性抑郁症患者静脉注射氯胺酮治疗的疗效与安全性:一项双盲、随机、安慰剂对照试验

2025-02-120
OA
Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography
2024-10-150
OAAI
Efficacy and safety of intravenous ketamine treatment in Japanese patients with treatment-resistant depression: A double-blind, randomized, placebo-controlled trial
2024-08-300
PRE